Abstract
• Benign breast diseases come to attention as imaging abnormality or as clinical symptom or as incidental pathological finding. Since most breast discoveries are benign, any new symptom can cause a natural anxiety that leads women to fear the worst. • For benign breast diseases, clinical classifications should be abandoned in favour of a simpler and comprehensive classification based on three histological categories: nonproliferative lesions, proliferative lesions without atypia and proliferative lesions with atypia. • Most benign breast disorders derive from minor aberrations of the normal processes of development, cyclical activity and involution. • Diagnostic assessment of benign lesions is planned to rule out cancer or associated high-risk lesions. Surgery of benign lesions is aimed at symptomatic relief. A good part of treatment is patient information and education.
Future directions. In the clinical practice, benign breast diseases represent a mostly negligible risk factor for BC. However, various studies demonstrate variability among the actual degree of risk, depending on whether lesions are proliferative and nonproliferative, with and without atypia, more or less associated with family history. The potential for research in benign breast diseases is endless. Studies on the link between benign breast disease and BC may help in discovering one of the many causes of BC.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
The Royal College of Surgeons. The breast clinic: benign breast diseases. https://www.rcsed.ac.uk/fellows/aaasalem/BenignbreastdiseaseDr.htm. Accessed 12 July 2014.
Mansel RE, Webster DJT, Sweetland HM. Aberrations of normal development and involution (ANDI): a concept of benign breast disorders based on pathogenesis. In: Hughes, Mansel & Webster’s benign disorders and diseases of the breast. London: Elsevier; 2009.
Laronga C, Tollin S, Thurlow M. Breast cysts: clinical manifestations, diagnosis, and management. http://www.uptodate.com. Accessed 18 Oct 2014.
Hindle WH. Fibrocystic changes. In: Hindle WH, editor. Breast care: a clinical guidebook for women’s primary health care providers. New York: Springer; 1999.
Grau AM, Chakravathy AB, Chug R. Phyllodes tumors of the breast. http://www.uptodate.com. Accessed 20 Feb 2014.
Al Sarakabi W, Worku D, Escobar PF, Mokbel K. Breast papillomas: current management with a focus on a new diagnostic and therapeutical modality. Int Semin Surg Oncol. 2006;3:1–8.
Warrick JI. Pathology of small, peripheral intraductal papillomas. http://emedicine.medscape.com/article/1873858-overview. Accessed 5 Jun 2013.
Sabel MS, Collins LC. Atypia and lobular carcinoma in situ: high risk lesions of the breast. http://www.uptodate.com. Accessed 20 Aug 2014.
NHSBSP Publication No 58: Oct 2005. NHSBSP Guidelines for Pathology Reporting in Breast Disease. http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp58.html. Accessed 30 Jan 2015.
Chinyama CN. Benign Breast Diseases. Berlin Heidelberg: Springer; 2014.
Kiluk JV, Geza A, Hoover SJ. High-Risk Benign Breast Lesions: Current Strategies in Management. Cancer Control. 2007;14:321–9.
Dupont WD, Page DL, Parl FF, et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med. 1994;331:10–5.
Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985;55:2698–708.
Verschuur-Maes AH, Witkamp AJ, De Bruin PC, et al. Progression risk of columnar cell lesions of the breast diagnosed in needle core biopsies. Int J Cancer. 2011;129:2674–80.
Lewis TJ, Hartmann LC, Maloney SD, et al. An analysis of breast cancer risk in women with simple multiple and atypical papillomas. Am J Surg Pathol. 2006;30:665–72.
Jacobs TW, Bryne C, Colditz G, Connolly JL, Schnitt SJ. Radial scars in benign breast biopsy specimens and the risk of breast cancer. N Engl J Med. 1999; 340:430–6.
Jensen RA, Page DL, Dupont WD, Rogers LW. Invasive breast cancer in women with sclerosing adenosis. Cancer. 1989;64:1977–83.
Further Reading
Castells X, Domingo L, Corominas JM, et al. Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program. Breast Cancer Res Treat. 2015;149:237–44.
Guray M, Sahin AA. Benign breast diseases: classification, diagnosis, and management. Oncologist. 2006;11:435–49.
Hartmann LC, Degnim AC, Santen RJ, Dupont WD, Ghosh K. Atypical hyperplasia of the breast–risk assessment and management options. N Engl J Med. 2015;372:78–89.
Moon HJ, Jung I, Kim MJ, Kim EK. Breast papilloma without atypia and risk of breast carcinoma. Breast J. 2014;20:525–33.
Morrow M, Schnitt SJ, Norton L. Current management of lesions associated with an increased risk of breast cancer. Nat Rev Clin Oncol. 2015. doi:10.1038/nrclinonc.2015.8.
Schwartz T, Cyr A, Margenthaler J. Screening breast magnetic resonance imaging in women with atypia or lobular carcinoma in situ. J Surg Res. 2015;193:519–22.
Wyss P, Varga Z, Rössle M, Rageth CJ. Papillary lesions of the breast: outcomes of 156 patients managed without excisional biopsy. Breast J. 2014;20:394–401.
Websites in Appendix: Benign Conditions, A-4.3.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Pluchinotta, A.M., Macellari, G., Lodovichetti, G. (2015). Benign Lesions of the Breast. In: Pluchinotta, A. (eds) The Outpatient Breast Clinic. Springer, Cham. https://doi.org/10.1007/978-3-319-15907-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-15907-2_9
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-15906-5
Online ISBN: 978-3-319-15907-2
eBook Packages: MedicineMedicine (R0)